0.8510
+0.1510
+(21.57%)
At close: January 31 at 2:07:53 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| YAG2.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/30/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/12/2024 |
| Maintains | Ascendiant Capital: Buy to Buy | 12/9/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/5/2024 |
Related Tickers
W2J.F Carisma Therapeutics, Inc.
0.5940
0.00%
2X10.F ABIVAX Société Anonyme
5.55
+0.91%
BX2.F BioXcel Therapeutics, Inc.
0.3289
+10.00%
PSH.F Sernova Corp.
0.1363
+0.22%
W1H.F Onco-Innovations Limited
1.3300
+2.31%
IFRX InflaRx N.V.
2.4100
+1.69%
CARM Carisma Therapeutics, Inc.
0.4598
-7.86%
HEPA Hepion Pharmaceuticals, Inc.
0.1795
-3.80%
PPCB Propanc Biopharma, Inc.
9.00
0.00%
DWTX Dogwood Therapeutics, Inc.
12.49
-2.12%